Equibles does not estimate personal net worth.
Get an email with a short summary when Skye Bioscience, Inc. publishes a filing, an earnings call transcript or a press release.
Get SKYE alertsTu Diep is recorded as COO at Skye Bioscience, Inc. (SKYE). The newest filing on record that lists Tu Diep as COO at Skye Bioscience, Inc. (SKYE) is dated April 16, 2026. Skye Bioscience, Inc. reported in an 8-K filed August 14, 2026 that Tu Diep resigned as executive officer, effective January 31, 2027. The proxy statement of Skye Bioscience, Inc. reports total compensation of $875,939 for Tu Diep in fiscal 2025, including a base salary of $440,000. Disclosed compensation is on record for 3 fiscal years. Tu Diep has spoken on 2 earnings calls across 1 company, most recently for Skye Bioscience, Inc. on March 10, 2026. Skye Bioscience, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Skye Bioscience, Inc. includes Lisa Anson (CEO), Punit Dhillon (CEO, Chief Accounting Officer and Board Member), Paul Grayson (Chairman and Board Member) and 7 others.
“In connection with the Transaction, on the date hereof, the Company entered into a separation agreement with Mr. Diep (the "Diep Separation Agreement") pursuant to which Mr. Diep's last day of employment with the Company will be January 31, 2027, unless he resigns or is terminated prior to such date”
“It is closer to 700 milligrams, you're right, not 600 milligrams. We did conduct a bioavailability study in the past. So this was an older study that was conducted to evaluate IV dosing versus sub-Q dosing.”
“But like Punit said, we've been digging in a lot with our own primary and secondary research.”
Start not stated–present
Last confirmed April 16, 2026
Proxy statement
Start not stated–2027-01-31
Biotechnology · Healthcare
COO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Skye Bioscience, Inc. (SKYE) | Chief Operating Officer | $440,000 | $875,939 |
| 2024 | Skye Bioscience, Inc. (SKYE) | Chief Operating Officer | $358,333 | $2,207,168 |
| 2023 | Skye Bioscience, Inc. (SKYE) | Chief Operating Officer | — | — |
